Li Jicheng, Zhou Jingjing, Weng Jingwen, Jin Fei, Shen Yanhua, Qi Yujie, Jiang Min, Hei Mingyan
Neonatal Center, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.
National Center for Children's Health, Beijing, 100045, China.
Pediatr Res. 2025 Feb;97(3):1058-1064. doi: 10.1038/s41390-024-03482-z. Epub 2024 Aug 15.
Rapidly progressive necrotizing enterocolitis (RP-NEC) is a particular subtype of NEC known for its rapid progression and high mortality rate. The objective of this study was to establish a predictive model for RP-NEC.
This was a retrospective single-center cohort study. Patients were newborn infants with NEC (Bell's stage ≥ IIB) admitted from January 1, 2016 to December 31, 2023. The primary outcome was RP-NEC defined as the need for surgical intervention and/or death within 48 hours of the onset of NEC.
Totally 334 newborn infants were included, among which 82 (24.6%) were RP-NEC cases with a gestation age 34.1 (31.0, 37.0) weeks and birth weight 2100 (1413, 2800) g. Plasma sodium <135 mmol/L, C-reactive protein ≥10 mg/L, platelet count <100 × 10/L, lymphocyte count <1.5 × 10/L, pH <7.2 in blood gas, and ascites at NEC onset were identified as independent risk factors for RP-NEC. The model established presented an AUC value of 0.983 (95% CI 0.97-0.99). The calibration curve for validation was applied revealing a slope close to unity while the Hosmer-Lemeshow test yielded χ = 2.550 (p = 0.636).
The predictive model established on the above 6 items of RP-NEC is highly promising.
Currently, there is a paucity of research on this specific type of severe necrotizing enterocolitis (NEC) characterized by rapid progression. Our study was to investigate the risk factors associated with surgical intervention and/or death within 48 hours following onset in infants with NEC, establish a predictive model for infants with rapidly progressive NEC. The new data presented in this study was the ROC curve combining the above factors as well as hyponatremia.
快速进展性坏死性小肠结肠炎(RP-NEC)是坏死性小肠结肠炎的一种特殊亚型,以进展迅速和高死亡率著称。本研究的目的是建立RP-NEC的预测模型。
这是一项回顾性单中心队列研究。患者为2016年1月1日至2023年12月31日收治的患有坏死性小肠结肠炎(贝尔分期≥IIB期)的新生儿。主要结局是RP-NEC,定义为在坏死性小肠结肠炎发病后48小时内需要手术干预和/或死亡。
共纳入334例新生儿,其中82例(24.6%)为RP-NEC病例,胎龄为34.1(31.0,37.0)周,出生体重为2100(1413,2800)g。血浆钠<135 mmol/L、C反应蛋白≥10 mg/L、血小板计数<100×10/L、淋巴细胞计数<1.5×10/L、血气pH<7.2以及坏死性小肠结肠炎发病时存在腹水被确定为RP-NEC的独立危险因素。所建立的模型AUC值为0.983(95%CI 0.97 - 0.99)。应用验证的校准曲线显示斜率接近1,而Hosmer-Lemeshow检验χ² = 2.550(p = 0.636)。
基于上述6项指标建立的RP-NEC预测模型前景广阔。
目前,针对这种以快速进展为特征的特定类型严重坏死性小肠结肠炎(NEC)的研究较少。我们的研究旨在调查坏死性小肠结肠炎婴儿发病后48小时内与手术干预和/或死亡相关的危险因素,建立快速进展性坏死性小肠结肠炎婴儿的预测模型。本研究呈现的新数据是结合上述因素以及低钠血症的ROC曲线。